Xencor, Inc. (XNCR)
USD 8.56
(-4.09%)
USD 8.56
(-4.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 283.55 Million USD | 138.75% |
| 2022 | 118.77 Million USD | 13.43% |
| 2021 | 104.7 Million USD | -19.95% |
| 2020 | 130.8 Million USD | 69.76% |
| 2019 | 77.04 Million USD | 39.96% |
| 2018 | 55.05 Million USD | -49.05% |
| 2017 | 108.05 Million USD | -5.72% |
| 2016 | 114.6 Million USD | 157.68% |
| 2015 | 44.47 Million USD | 421.25% |
| 2014 | 8.53 Million USD | -38.08% |
| 2013 | 13.78 Million USD | -55.77% |
| 2012 | 31.16 Million USD | -6.45% |
| 2011 | 33.31 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 263.62 Million USD | -3.1% |
| 2024 Q1 | 272.06 Million USD | -4.05% |
| 2023 Q4 | 283.55 Million USD | 159.15% |
| 2023 FY | 283.55 Million USD | 138.75% |
| 2023 Q2 | 99.24 Million USD | -17.18% |
| 2023 Q1 | 119.82 Million USD | 0.89% |
| 2023 Q3 | 109.42 Million USD | 10.25% |
| 2022 Q2 | 108.98 Million USD | 14.84% |
| 2022 Q4 | 118.77 Million USD | 5.51% |
| 2022 FY | 118.77 Million USD | 13.43% |
| 2022 Q1 | 94.89 Million USD | -9.37% |
| 2022 Q3 | 112.57 Million USD | 3.29% |
| 2021 Q4 | 104.7 Million USD | 33.55% |
| 2021 Q1 | 109.12 Million USD | -16.57% |
| 2021 Q2 | 48.66 Million USD | -55.41% |
| 2021 Q3 | 78.4 Million USD | 61.11% |
| 2021 FY | 104.7 Million USD | -19.95% |
| 2020 Q2 | 74.07 Million USD | 0.16% |
| 2020 Q3 | 77.86 Million USD | 5.12% |
| 2020 Q4 | 130.8 Million USD | 67.98% |
| 2020 FY | 130.8 Million USD | 69.76% |
| 2020 Q1 | 73.95 Million USD | -4.01% |
| 2019 Q1 | 87.43 Million USD | 58.83% |
| 2019 FY | 77.04 Million USD | 39.96% |
| 2019 Q2 | 76.66 Million USD | -12.32% |
| 2019 Q4 | 77.04 Million USD | 1.37% |
| 2019 Q3 | 76 Million USD | -0.85% |
| 2018 Q3 | 53.31 Million USD | -26.24% |
| 2018 Q4 | 55.05 Million USD | 3.26% |
| 2018 FY | 55.05 Million USD | -49.05% |
| 2018 Q1 | 74.6 Million USD | -30.95% |
| 2018 Q2 | 72.27 Million USD | -3.12% |
| 2017 Q2 | 114.79 Million USD | 0.21% |
| 2017 Q3 | 107.71 Million USD | -6.17% |
| 2017 Q4 | 108.05 Million USD | 0.32% |
| 2017 FY | 108.05 Million USD | -5.72% |
| 2017 Q1 | 114.55 Million USD | -0.05% |
| 2016 FY | 114.6 Million USD | 157.68% |
| 2016 Q2 | 125.68 Million USD | 257.59% |
| 2016 Q1 | 35.14 Million USD | -20.98% |
| 2016 Q4 | 114.6 Million USD | -4.26% |
| 2016 Q3 | 119.71 Million USD | -4.75% |
| 2015 Q4 | 44.47 Million USD | -23.53% |
| 2015 FY | 44.47 Million USD | 421.25% |
| 2015 Q3 | 58.16 Million USD | 454.23% |
| 2015 Q2 | 10.49 Million USD | 12.4% |
| 2015 Q1 | 9.33 Million USD | 9.42% |
| 2014 Q3 | 11.15 Million USD | 2.82% |
| 2014 Q1 | 12.43 Million USD | -9.8% |
| 2014 Q4 | 8.53 Million USD | -23.52% |
| 2014 FY | 8.53 Million USD | -38.08% |
| 2014 Q2 | 10.85 Million USD | -12.7% |
| 2013 Q2 | 17.33 Million USD | 0.0% |
| 2013 Q3 | 15.63 Million USD | -9.82% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 13.78 Million USD | -55.77% |
| 2013 Q4 | 13.78 Million USD | -11.85% |
| 2012 Q4 | 31.16 Million USD | 0.0% |
| 2012 FY | 31.16 Million USD | -6.45% |
| 2011 FY | 33.31 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | 15.551% |
| Alkermes plc | 933.53 Million USD | 69.625% |
| Agenus Inc. | 462.29 Million USD | 38.663% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 92.999% |
| Aptorum Group Limited | 5.25 Million USD | -5294.201% |
| Ardelyx, Inc. | 130.76 Million USD | -116.85% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 40.726% |
| Bicycle Therapeutics plc | 224.41 Million USD | -26.356% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -117.771% |
| ChromaDex Corporation | 26.5 Million USD | -969.711% |
| Chimerix, Inc. | 19.74 Million USD | -1336.105% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -706.089% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -290.755% |
| CRISPR Therapeutics AG | 346.76 Million USD | 18.228% |
| Precision BioSciences, Inc. | 140.92 Million USD | -101.22% |
| Dyadic International, Inc. | 2.34 Million USD | -12014.536% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1643.584% |
| Fortress Biotech, Inc. | 165.93 Million USD | -70.881% |
| Lantern Pharma Inc. | 2.73 Million USD | -10250.07% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -296.697% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7935.735% |
| Incyte Corporation | 1.59 Billion USD | 82.192% |
| IO Biotech, Inc. | 17.55 Million USD | -1515.169% |
| Jaguar Health, Inc. | 45.86 Million USD | -518.234% |
| Novavax, Inc. | 2.57 Billion USD | 88.976% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -686.397% |
| Opthea Limited | 264.6 Million USD | -7.165% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -116.942% |
| ContextLogic Inc. | 206 Million USD | -37.65% |
| MiMedx Group, Inc. | 96.33 Million USD | -194.362% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -490.477% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7935.366% |
| NextCure, Inc. | 14.99 Million USD | -1790.771% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6915.314% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -4146.802% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -506.686% |
| Vaxcyte, Inc. | 167.44 Million USD | -69.341% |
| PDS Biotechnology Corporation | 33.25 Million USD | -752.575% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -20.554% |
| Pharming Group N.V. | 244.07 Million USD | -16.178% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2278.452% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -121.893% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4191.615% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4191.615% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -243.987% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -4168.538% |
| Acelyrin, Inc. | 86.35 Million USD | -228.372% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -21724.973% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1872.036% |
| Summit Therapeutics Inc. | 125.25 Million USD | -126.382% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2891.444% |
| Senti Biosciences, Inc. | 52.57 Million USD | -439.383% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -312.288% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -87.153% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -14396.881% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -21131.405% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -25.008% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2927.213% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -24.671% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 42.658% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2498.122% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -930.711% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2242.553% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 41.727% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7518.902% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -649.918% |
| MEI Pharma, Inc. | 8.35 Million USD | -3293.884% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -877.284% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 18.419% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -94.393% |
| Fortress Biotech, Inc. | 165.93 Million USD | -70.881% |
| Precigen, Inc. | 41.64 Million USD | -580.912% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -467.913% |
| AlloVir, Inc. | 45.01 Million USD | -529.921% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -117.558% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -105.776% |
| ImmuCell Corporation | 18.81 Million USD | -1407.088% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -904.602% |
| Onconetix, Inc. | 23.18 Million USD | -1123.245% |
| PureTech Health plc | 125.58 Million USD | -125.794% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -3068.257% |
| Elevation Oncology, Inc. | 34.28 Million USD | -727.137% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -11497.505% |
| Seer, Inc. | 39.36 Million USD | -620.333% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -358.581% |
| Innoviva, Inc. | 568.55 Million USD | 50.126% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -941.424% |
| ESSA Pharma Inc. | 3.49 Million USD | -8013.111% |
| GlycoMimetics, Inc. | 6.9 Million USD | -4008.316% |
| GT Biopharma, Inc. | 6.63 Million USD | -4174.974% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -7.25% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -4.14% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -237.466% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2801.156% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -943.686% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8690.42% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -284.398% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1693.689% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2468.542% |
| Soligenix, Inc. | 7.27 Million USD | -3797.77% |
| Century Therapeutics, Inc. | 175.94 Million USD | -61.167% |
| Kura Oncology, Inc. | 51.66 Million USD | -448.873% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -133.801% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6760.852% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -4187.348% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -12.257% |
| Autolus Therapeutics plc | 263.9 Million USD | -7.447% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2605.199% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -219.104% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -504.616% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 19.639% |
| GRI Bio, Inc. | 2.69 Million USD | -10413.867% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -34925.229% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -812.029% |
| IGM Biosciences, Inc. | 220.17 Million USD | -28.787% |
| INmune Bio, Inc. | 18.86 Million USD | -1403.335% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -10.558% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -964.338% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10331.076% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -8544.39% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -385.089% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -194.886% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -7.111% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 65.547% |
| Verastem, Inc. | 71.18 Million USD | -298.341% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -476.621% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -635.028% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -479.496% |
| Histogen Inc. | 5.69 Million USD | -4877.339% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -6365.676% |
| Surrozen, Inc. | 8.14 Million USD | -3381.387% |
| Organovo Holdings, Inc. | 2.74 Million USD | -10218.741% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -90246.271% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -404.285% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1617.29% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -454.877% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -34192.85% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -123.759% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2522.247% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -87.926% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10775.392% |
| Apollomics, Inc. | 14.15 Million USD | -1903.526% |
| Amarin Corporation plc | 279.58 Million USD | -1.421% |
| Mesoblast Limited | 188.79 Million USD | -50.192% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1904.234% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -56.846% |
| Synaptogenix, Inc. | 5.52 Million USD | -5028.142% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -4165.328% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -66.694% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3213.692% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -16035.207% |
| Exelixis, Inc. | 678.44 Million USD | 58.205% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1089.326% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -72.853% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 52.28% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2554.996% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -17364.659% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -628.438% |
| Gritstone bio, Inc. | 125.91 Million USD | -125.192% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1832.127% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5472.407% |
| Avid Bioservices, Inc. | 275.66 Million USD | -2.863% |
| Insmed Incorporated | 1.66 Billion USD | 82.936% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3585.445% |
| MediWound Ltd. | 27.18 Million USD | -942.995% |
| OmniAb, Inc. | 87.4 Million USD | -224.438% |
| Alector, Inc. | 487.66 Million USD | 41.854% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 29.717% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1438.991% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -638.954% |
| Zai Lab Limited | 240.17 Million USD | -18.063% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 54.995% |
| Aura Biosciences, Inc. | 29.22 Million USD | -870.195% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -198.241% |
| Immunic, Inc. | 25.36 Million USD | -1017.782% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -309.554% |
| Veracyte, Inc. | 93.71 Million USD | -202.563% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10736.623% |
| FibroGen, Inc. | 585.72 Million USD | 51.589% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1531.243% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -43318.99% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4913.9% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.296% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3358.88% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -237.482% |
| TG Therapeutics, Inc. | 169.08 Million USD | -67.702% |
| Galecto, Inc. | 5.89 Million USD | -4709.345% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3322.972% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.171% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -883.828% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2146.724% |
| XBiotech Inc. | 8.39 Million USD | -3276.908% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1832.127% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -433.206% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 21.907% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -954.75% |
| Theravance Biopharma, Inc. | 169 Million USD | -67.782% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 76.673% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 43.336% |
| Vaxxinity, Inc. | 30.94 Million USD | -816.362% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 70.842% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4601.608% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 61.95% |
| NexImmune, Inc. | 5.08 Million USD | -5477.224% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -76249.914% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -9121.887% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.01% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5401.695% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3703.897% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -978.417% |
| Ainos, Inc. | 7.39 Million USD | -3734.872% |
| Pluri Inc. | 34.11 Million USD | -731.259% |
| Prothena Corporation plc | 135.01 Million USD | -110.017% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -16.642% |
| Celularity Inc. | 102.92 Million USD | -175.49% |
| Rallybio Corporation | 9.43 Million USD | -2905.076% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1059.988% |
| MeiraGTx Holdings plc | 319.99 Million USD | 11.385% |
| Omeros Corporation | 403.25 Million USD | 29.682% |
| Humacyte, Inc. | 114.67 Million USD | -147.268% |
| Immunocore Holdings plc | 228.15 Million USD | -24.282% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5716.595% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -269.506% |
| Blueprint Medicines Corporation | 918.64 Million USD | 69.133% |
| CalciMedica, Inc. | 4.02 Million USD | -6939.697% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1524.794% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -83.958% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -230.423% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -2.076% |
| Pulmatrix, Inc. | 15.96 Million USD | -1676.352% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1697.749% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1052.398% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -13.058% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -458.341% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 76.578% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -792.172% |
| Nutriband Inc. | 1.07 Million USD | -26181.769% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2566.783% |
| Vor Biopharma Inc. | 59.1 Million USD | -379.763% |
| Roivant Sciences Ltd. | 773.95 Million USD | 63.362% |
| Evogene Ltd. | 17.99 Million USD | -1476.203% |
| ProKidney Corp. | 29.21 Million USD | -870.561% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -293.947% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -40122.105% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 84.988% |
| CorMedix Inc. | 11.91 Million USD | -2279.344% |
| BioLineRx Ltd. | 50.7 Million USD | -459.266% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -89.724% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -220.619% |
| Atai Life Sciences N.V. | 49.16 Million USD | -476.785% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -810.234% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1478.661% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -127.51% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4915.193% |
| MediciNova, Inc. | 3.89 Million USD | -7186.525% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1451.283% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18750.636% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7955.926% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 28.621% |
| Biomea Fusion, Inc. | 30.69 Million USD | -823.946% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 89.582% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1676.463% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -808.814% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -383.196% |
| Absci Corporation | 58.3 Million USD | -386.346% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1388.655% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -784.408% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -284.278% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -224.13% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -739.677% |
| Allakos Inc. | 74.79 Million USD | -279.125% |
| Imunon, Inc. | 8.53 Million USD | -3224.089% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1160.206% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -146.977% |
| BioAtla, Inc. | 48.98 Million USD | -478.857% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2554.996% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -10103.634% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -117.114% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1894.787% |
| XOMA Corporation | 145.58 Million USD | -94.779% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -742.296% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -312.395% |
| aTyr Pharma, Inc. | 31.59 Million USD | -797.424% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -358.663% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -530.622% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -485.841% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9780.105% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3375.832% |
| Akari Therapeutics, Plc | 4.58 Million USD | -6085.842% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1499.035% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 82.809% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -70103.858% |
| UroGen Pharma Ltd. | 243.52 Million USD | -16.44% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 11.688% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -10168.081% |
| Orgenesis Inc. | 35.53 Million USD | -697.971% |
| Entera Bio Ltd. | 1.37 Million USD | -20462.654% |
| GH Research PLC | 6.7 Million USD | -4131.592% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -4069.985% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1406.209% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -9397.316% |
| Replimune Group, Inc. | 113.21 Million USD | -150.463% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -7447.234% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -173.891% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -70103.858% |
| Portage Biotech Inc. | 4.45 Million USD | -6272.112% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -18750.636% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1130.191% |
| OncoCyte Corporation | 49.29 Million USD | -475.194% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6754.541% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -35456.701% |
| Purple Biotech Ltd. | 10 Million USD | -2734.173% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4800.778% |
| scPharmaceuticals Inc. | 57.26 Million USD | -395.204% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2188.977% |
| HilleVax, Inc. | 78.9 Million USD | -259.349% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5515.03% |
| Tharimmune, Inc. | 1.81 Million USD | -15522.689% |
| Genprex, Inc. | 3.25 Million USD | -8613.61% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -945.61% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -5315.565% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -137550.0% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -78985.367% |
| OKYO Pharma Limited | 7.42 Million USD | -3721.114% |
| Savara Inc. | 37.19 Million USD | -662.419% |
| Curis, Inc. | 57.61 Million USD | -392.187% |
| Daré Bioscience, Inc. | 26.32 Million USD | -976.949% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -623.369% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -19537.05% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1262.02% |
| BeiGene, Ltd. | 2.23 Billion USD | 87.306% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1231.901% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -8.065% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1232.89% |
| Erasca, Inc. | 78.61 Million USD | -260.712% |
| bluebird bio, Inc. | 424.62 Million USD | 33.221% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -43174.801% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 84.997% |
| DBV Technologies S.A. | 42.8 Million USD | -562.521% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -43174.801% |
| Moderna, Inc. | 4.57 Billion USD | 93.798% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3953.738% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -17023.128% |
| Molecular Templates, Inc. | 31.17 Million USD | -809.688% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1561.154% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 51.784% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -127.749% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -933.491% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -677.812% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -409.677% |
| MacroGenics, Inc. | 154.2 Million USD | -83.882% |
| RenovoRx, Inc. | 4.46 Million USD | -6249.283% |
| Adicet Bio, Inc. | 37.12 Million USD | -663.898% |
| Prime Medicine, Inc. | 60.78 Million USD | -366.533% |
| Aditxt, Inc. | 28.53 Million USD | -893.843% |
| Adagene Inc. | 45.16 Million USD | -527.769% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -156821.655% |
| Quantum-Si incorporated | 26.63 Million USD | -964.77% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 59.35% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -9220.124% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -146.657% |
| SciSparc Ltd. | 1.59 Million USD | -17677.994% |
| Vericel Corporation | 127.7 Million USD | -122.042% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4995.497% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -232.199% |
| Generation Bio Co. | 171.63 Million USD | -65.215% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2355.056% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -577.868% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -12.213% |
| Invivyd, Inc. | 51.71 Million USD | -448.332% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -208.293% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -4258.925% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -275.595% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -27672.674% |
| 2seventy bio, Inc. | 310.12 Million USD | 8.567% |
| ADMA Biologics, Inc. | 193.97 Million USD | -46.183% |
| Clene Inc. | 38.95 Million USD | -627.989% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -684.768% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -10.345% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7955.926% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -49.035% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2228.135% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -42.979% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2225.245% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -489.385% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -436.627% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 23.332% |
| Evaxion Biotech A/S | 17.61 Million USD | -1509.532% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -76.201% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -85.108% |
| Trevena, Inc. | 48.26 Million USD | -487.541% |
| Surrozen, Inc. | 8.14 Million USD | -3381.387% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1213.077% |
| Cingulate Inc. | 10.36 Million USD | -2636.827% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -10211.236% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -660.375% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7806.243% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2056.342% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 10.606% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1041.128% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7754.803% |
| Kronos Bio, Inc. | 54.2 Million USD | -423.162% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -502.766% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1145.88% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1312.78% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1150.456% |
| ImmunityBio, Inc. | 1.09 Billion USD | 73.995% |
| Korro Bio, Inc. | 51.75 Million USD | -447.919% |
| Kineta, Inc. | 7.22 Million USD | -3826.322% |
| BioVie Inc. | 9.7 Million USD | -2822.647% |
| Codexis, Inc. | 49.94 Million USD | -467.731% |
| Celularity Inc. | 102.92 Million USD | -175.49% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -194.616% |
| Celcuity Inc. | 51.45 Million USD | -451.134% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -82044.823% |
| Cibus, Inc. | 206.11 Million USD | -37.572% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -567.59% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -976.575% |
| IN8bio, Inc. | 8.77 Million USD | -3132.547% |
| Kodiak Sciences Inc. | 213.59 Million USD | -32.758% |
| Annexon, Inc. | 47.11 Million USD | -501.806% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -216.681% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -194.234% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1971.437% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.108% |
| Eyenovia, Inc. | 19.78 Million USD | -1333.544% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -60.125% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3591.694% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1076.642% |
| Arcellx, Inc. | 339.75 Million USD | 16.539% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2283.249% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -15.484% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2865.168% |
| Moolec Science SA | 13.94 Million USD | -1933.358% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -557.117% |
| Geron Corporation | 146.12 Million USD | -94.05% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -461.147% |
| Royalty Pharma plc | 6.29 Billion USD | 95.497% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -612.89% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -96215.632% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -11425.467% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -49.907% |
| Humacyte, Inc. | 114.67 Million USD | -147.268% |
| Structure Therapeutics Inc. | 29.05 Million USD | -876.073% |
| 89bio, Inc. | 59.96 Million USD | -372.89% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -971.53% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -23608.946% |
| Genelux Corporation | 8.42 Million USD | -3267.684% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -4035.925% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -108.011% |
| Notable Labs, Ltd. | 4.42 Million USD | -6305.218% |
| Liquidia Corporation | 73.13 Million USD | -287.704% |
| Mustang Bio, Inc. | 17.61 Million USD | -1509.393% |
| Immunovant, Inc. | 48.95 Million USD | -479.224% |
| Quantum-Si incorporated | 26.63 Million USD | -964.77% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -638.762% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -9038.221% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -283.909% |
| Acasti Pharma Inc. | 11.55 Million USD | -2353.569% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1154.257% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -10331.076% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -668.932% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -20706.447% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4551.558% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1041.772% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1123.081% |
| PepGen Inc. | 34.63 Million USD | -718.801% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2234.972% |
| United Therapeutics Corporation | 1.18 Billion USD | 76.014% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3960.123% |
| Solid Biosciences Inc. | 38.45 Million USD | -637.321% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3213.692% |
| Immuneering Corporation | 12 Million USD | -2261.348% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -90246.271% |
| Silo Pharma, Inc. | 1.56 Million USD | -17969.485% |
| Belite Bio, Inc | 4.21 Million USD | -6633.769% |
| XOMA Corporation | 145.58 Million USD | -94.779% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -11578.707% |
| Bionomics Limited | 10.15 Million USD | -2691.286% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1219.431% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1137.546% |
| uniQure N.V. | 624.01 Million USD | 54.559% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1897.598% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -156821.655% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -66.619% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7634.834% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -108717.152% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -4102.742% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3591.694% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1531.243% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2583.185% |
| Altimmune, Inc. | 16.54 Million USD | -1614.28% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 54.095% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1137.546% |
| Compugen Ltd. | 55.77 Million USD | -408.398% |
| Peak Bio, Inc. | 20.75 Million USD | -1266.328% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -156.7% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5614.611% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -79.646% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -277.204% |
| Zura Bio Limited | 21.29 Million USD | -1231.763% |
| PolyPid Ltd. | 17.46 Million USD | -1523.305% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -152.279% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -277.204% |
| Instil Bio, Inc. | 99.8 Million USD | -184.124% |
| argenx SE | 444.95 Million USD | 36.272% |
| Immunome, Inc. | 28.65 Million USD | -889.458% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3301.211% |
| Verona Pharma plc | 58.84 Million USD | -381.907% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1859.228% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1808.332% |
| CervoMed Inc. | 2.59 Million USD | -10823.985% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5717.788% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2126.437% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2591.59% |
| Moolec Science SA | 13.94 Million USD | -1933.358% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -11999.787% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -410.041% |
| AnaptysBio, Inc. | 364.28 Million USD | 22.16% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2271.688% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2135.564% |
| NeurAxis, Inc. | 1.91 Million USD | -14724.762% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -628.419% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2026.746% |
| Achilles Therapeutics plc | 19.08 Million USD | -1385.613% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1859.228% |
| 180 Life Sciences Corp. | 5.38 Million USD | -5163.56% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1102.133% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1145.88% |
| Nutriband Inc. | 1.07 Million USD | -26181.769% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -826.724% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1854.097% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 29.335% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -773.215% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2073.016% |
| Palisade Bio, Inc. | 2.73 Million USD | -10252.647% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -5298.039% |
| Beam Therapeutics Inc. | 478.38 Million USD | 40.726% |
| Neurogene Inc. | 36.54 Million USD | -675.832% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 28.745% |
| AEON Biopharma, Inc. | 159.88 Million USD | -77.347% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -495.087% |
| Sesen Bio, Inc. | 30.98 Million USD | -815.179% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -992.25% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3629.952% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -44.867% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -47.643% |
| Athira Pharma, Inc. | 30.05 Million USD | -843.404% |
| Vaccinex, Inc. | 5.94 Million USD | -4672.114% |
| HCW Biologics Inc. | 15.05 Million USD | -1783.87% |
| XOMA Corporation | 145.58 Million USD | -94.779% |
| Nektar Therapeutics | 267.04 Million USD | -6.184% |
| Arvinas, Inc. | 644.6 Million USD | 56.01% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1499.035% |
| Merus N.V. | 102.15 Million USD | -177.588% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -93.754% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -198.107% |
| Rezolute, Inc. | 11.73 Million USD | -2316.559% |
| Clene Inc. | 38.95 Million USD | -627.989% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9858.594% |
| BeyondSpring Inc. | 48.26 Million USD | -487.456% |
| Synlogic, Inc. | 32.89 Million USD | -762.012% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1840.457% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -17253.672% |
| Peak Bio, Inc. | 20.75 Million USD | -1266.328% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -346.838% |
| Krystal Biotech, Inc. | 39.71 Million USD | -614.003% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 24.714% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -184.786% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -65428.533% |
| MannKind Corporation | 721.36 Million USD | 60.691% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1169.572% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -13493.432% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -176.4% |
| Gossamer Bio, Inc. | 249.14 Million USD | -13.812% |
| CohBar, Inc. | 1.03 Million USD | -27333.105% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2552.811% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1388.655% |
| Legend Biotech Corporation | 589.93 Million USD | 51.934% |
| Mural Oncology plc | 37.92 Million USD | -647.624% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -113.787% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -12253.725% |
| Disc Medicine, Inc. | 22.87 Million USD | -1139.602% |
| Champions Oncology, Inc. | 28.03 Million USD | -911.446% |
| REGENXBIO Inc. | 262.22 Million USD | -8.135% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -8340.884% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2162.318% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2011.129% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1237.227% |
| Vaxart, Inc. | 34.02 Million USD | -733.384% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1290.727% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -893.832% |
| Cellectis S.A. | 249.57 Million USD | -13.617% |
| Longeveron Inc. | 5.33 Million USD | -5213.079% |
| Repare Therapeutics Inc. | 41.81 Million USD | -578.063% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 88.211% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -369.717% |
| Revolution Medicines, Inc. | 262.39 Million USD | -8.065% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -13357.95% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3187.259% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2302.839% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1919.22% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -13082.659% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.494% |
| Denali Therapeutics Inc. | 122.96 Million USD | -130.605% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4995.497% |
| Veru Inc. | 32.81 Million USD | -764.174% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -4028.097% |
| Cingulate Inc. | 10.36 Million USD | -2636.827% |
| Passage Bio, Inc. | 39.26 Million USD | -622.223% |
| Context Therapeutics Inc. | 4.19 Million USD | -6664.749% |
| Exicure, Inc. | 8.54 Million USD | -3216.867% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -860.956% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2604.167% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1186.507% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -73.978% |
| Nuvalent, Inc. | 31.82 Million USD | -791.05% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4357.335% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -349.937% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1475.328% |
| OmniAb, Inc. | 87.4 Million USD | -224.438% |
| Anew Medical, Inc. | 8.24 Million USD | -3340.499% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -640.574% |
| Lipocine Inc. | 2.63 Million USD | -10675.037% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -979.32% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -605.16% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -964.338% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -229.13% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -5150.12% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -242.682% |
| Ocugen, Inc. | 23.98 Million USD | -1082.333% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -511.026% |
| Q32 Bio Inc. | 233.12 Million USD | -21.632% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -3027.719% |
| Alumis Inc. Common Stock | 53.5 Million USD | -429.997% |
| Equillium, Inc. | 27.95 Million USD | -914.268% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -37.256% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4939.557% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4523.52% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -80.237% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -308.392% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2742.924% |
| Dominari Holdings Inc. | 4.63 Million USD | -6017.778% |
| Edesa Biotech, Inc. | 1.84 Million USD | -15297.117% |
| vTv Therapeutics Inc. | 29.56 Million USD | -859.039% |
| Bio-Techne Corporation | 744.34 Million USD | 61.905% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -124.87% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 17.679% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -598.852% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -879.242% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -207.015% |
| Nkarta, Inc. | 105.6 Million USD | -168.522% |
| BioCardia, Inc. | 4.59 Million USD | -6077.756% |
| Iterum Therapeutics plc | 32.66 Million USD | -768.162% |